RA Capital Management’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.9M | Hold |
4,563,211
| – | – | 0.29% | 40 |
|
|
2025
Q1 | $14.7M | Hold |
4,563,211
| – | – | 0.25% | 57 |
|
|
2024
Q4 | $25.4M | Sell |
4,563,211
-535,000
| -10% | -$2.98M | 0.34% | 49 |
|
|
2024
Q3 | $55.1M | Hold |
5,098,211
| – | – | 0.64% | 35 |
|
|
2024
Q2 | $107M | Buy |
5,098,211
+46,700
| +0.9% | +$980K | 1.42% | 21 |
|
|
2024
Q1 | $161M | Buy |
5,051,511
+888,300
| +21% | +$28.3M | 2.05% | 12 |
|
|
2023
Q4 | $84.3M | Hold |
4,163,211
| – | – | 1.32% | 22 |
|
|
2023
Q3 | $53M | Buy |
4,163,211
+1,093,680
| +36% | +$13.9M | 1.04% | 28 |
|
|
2023
Q2 | $55.5M | Buy |
+3,069,531
| New | +$55.5M | 1.05% | 29 |
|